Bone Metastasis Therapeutics Market Estimated to Flourish by 2024 - Persistence Market Research
According to study results from Minneapolis Medical Research Foundation, in 2012, over 280,000 patients were living with bone metastasis in the U.S. with breast and prostate cancers being the most common primary tumor types. Metastasis is the unique hallmark of cancer cells which differentiates them from the benign tumors, which refers to the spread of cancer from its primary site to other body parts. Bone is the third most common site for the spread of cancer and invasion of such...
View full press release